Annual report pursuant to Section 13 and 15(d)

Revenue Information

v3.20.1
Revenue Information
 12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Revenue Information

Note 13 – Revenue Information

 

Revenue by product lines was as follows:

 

    Years Ended  
    December 31,  
Product Line   2019     2018  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 126,150     $ 123,941  
Particle ImmunoFiltration Assay (“PIFA”)     1,327,752       1,422,361  
Rapid Enzymatic Assay (“REA”)     85,000       68,750  
Other     38,131       50,518  
Total Revenue   $ 1,577,033     $ 1,665,570  

 

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Years Ended  
    December 31,  
Geographic Region   2019     2018  
United States   $ 1,559,533     $ 1,576,765  
Rest of World     17,500       88,805  
Total Revenue   $ 1,577,033     $ 1,665,570  

 

The Company had long-lived assets totaling $194,174 and $312,572 located in the United States and $9,823 and $14,295 located in the Rest of the World as of December 31, 2019 and 2018, respectively.